SARAH ARAGON: Open Payments
NPI 1437402450 · SANTA FE, NM. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,394 in 57 payments from 14 companies in 2025. Trend: 2023 $18 · 2024 $0 · 2025 $1,394
Food & beverage: $1,233Education: $161
| Company | Payments | Amount |
|---|---|---|
| Janssen Biotech, Inc. | 14 | $455 |
| ABBVIE INC. | 18 | $274 |
| PFIZER INC. | 4 | $156 |
| Ardelyx, Inc. | 4 | $104 |
| Takeda Pharmaceuticals U.S.A., Inc. | 3 | $91 |
| Madrigal Pharmaceuticals | 3 | $84 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 3 | $57 |
| GENZYME CORPORATION | 2 | $42 |
| Ipsen Biopharmaceuticals, Inc | 1 | $27 |
| QOL Medical, LLC | 1 | $23 |
Products named: TREMFYA, RINVOQ, VELSIPITY, IBSRELA, REZDIFFRA, MAVYRET, DUPIXENT, ENTYVIO.
Industry payments across NM — which companies pay providers there.
